Fluoroquinolones for treating typhoid and paratyphoid fever (enteric fever)
Background Fluoroquinolones are recommended as first-line therapy for typhoid and paratyphoid fever (enteric fever), but how they compare with other antibiotics and different fluoroquinolones is unclear. Objectives To evaluate fluoroquinolone antibiotics
Critchley JA +5 more
core +3 more sources
Fluoroquinolones for treating tuberculosis (presumed drug-sensitive).
Currently the World Health Organization only recommend fluoroquinolones for people with presumed drug-sensitive tuberculosis (TB) who cannot take standard first-line drugs.
Ziganshina L., Titarenko A., Davies G.
core
Factors Influencing Fluoroquinolone Resistance
Daniel F. Sahm +3 more
doaj +1 more source
Redefining Fluoroquinolone Antibiotics: Design and Synthesis of Degradable Fluoroquinolones to Reduce Environmental Persistence. [PDF]
Raeymackers N +6 more
europepmc +1 more source
Levofloxacin-associated tendon disorders: Sex-, age-, and route-specific disproportionality analysis using FAERS and JADER. [PDF]
Nakashima T +3 more
europepmc +1 more source
Promoting Sustainable Prescribing-A Case Study Presenting Experiences From Two Swedish Drug and Therapeutics Committees. [PDF]
Ericsson B +5 more
europepmc +1 more source
Packaged intervention targeting oral antimicrobials in Japanese tertiary care outpatient setting: a quasi-experimental study. [PDF]
Horiuchi H +4 more
europepmc +1 more source
Testosterone Therapy in a Patient With Fluoroquinolone-Associated Tendinopathy: A Case Report of Rapid-Onset Achilles Injury Following Ciprofloxacin. [PDF]
Farzam K.
europepmc +1 more source
Burden of Multidrug-Resistant Uropathogens and Their Antimicrobial Susceptibility Among Hospitalized Patients: A Single-Center Retrospective Analysis. [PDF]
Rohatgi D, Moorjani H.
europepmc +1 more source
Fluoroquinolones and tendon disorders
Fluoroquinolones are the most potent oral antibiotics in clinical use today. Increasingly, these drugs are being prescribed for relatively benign infections and for new categories of patients, including paediatric patients.
Melhus, Åsa,
core

